Venture Capital

Pearson hit 2025 targets with strong Q4 growth, but its aggressive push into AI and major tech partnerships with Microsoft and IBM is the real story.

After nearly half a century, the JLPGA tour is back in Taiwan, fueled by tech giants Foxconn and SoftBank and a record-breaking US$2 million purse.

Dr. Toby Kiers wins the Tyler Prize for her work on fungi, as her NGO launches a new program to legally protect these vital underground ecosystems.

A new partnership aims to bring a revolutionary, disease-modifying stem cell therapy for knee osteoarthritis to millions of patients in Greater China.

A new global league is bringing elite basketball to Tokyo, but its revolutionary athlete-owner model, starring Japan's Mai Yamamoto, is the real game-changer.

One year in, Taiwan's state-backed startup hub is embedding its hardware prowess into U.S. AI innovation, deepening a critical tech alliance.

Medtech firm IMPLANET reports a landmark €12.5M revenue year, fueled by strong international sales, US growth, and a strategic pivot into robotics.

Moving beyond hype, ArisGlobal's record growth and enterprise adoption of its NavaX AI show the pharmaceutical industry is now operationalizing AI at scale.

With a new finance head, the non-profit plans to launch a breakthrough vitamin A product in Africa, blending philanthropy with commercial strategy.

With a sold-out show, Work Truck Week 2026 is a launchpad for new EVs, hydrogen tech, and smart systems, signaling a robust future for commercial vehicles.

Rivian's RJ Scaringe and Mack's Stephen Roy will keynote ACT Expo 2026, signaling a new era where fleet electrification meets AI-driven intelligence.

Genomics giant Illumina launches a vast biological dataset with pharma partners, aiming to train AI and revolutionize how we find new medicines.

The U.S. Army partners with Velo3D, using advanced 3D printing to create mission-critical metal parts and bolster the readiness of its combat fleet.

With three new executive appointments, Armada signals an aggressive new strategy under CEO Chris O'Brien to unify its brand and accelerate growth.

A new alliance aims to solve a critical scaling bottleneck in photonic quantum computing, accelerating the race to build a useful, large-scale machine.

O Positiv's new menopause and metabolism products at Target signal a market shift. But how strong is the science behind these 'clinically studied' formulas?

Goldflower Cannabis expands to Fort Pierce, launching 'The Freedom Roll' to aid cannabis prisoners and veterans, blending rapid growth with social equity.

Propanc Biopharma is taking a 100-year-old cancer treatment concept into modern human trials, targeting advanced tumors and expanding into fibrosis.

Unveiled at CES 2026, this award-winning expandable home on wheels promises AI-powered, self-sufficient living for a new generation of nomads.

A novel vaccine protects shrimp by immunizing their parents, offering a solution to devastating outbreaks and a path to sustainable global protein production.